• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15922 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2012 Penn Medicine Center for Evidence-based Practice (CEP) Composite indexes of provider performance
2012 Penn Medicine Center for Evidence-based Practice (CEP) Biliary drainage for chemotherapy patients
2012 Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for use of screening and preventive services
2012 Penn Medicine Center for Evidence-based Practice (CEP) Reconciliation of data from differing electronic medical records
2012 Penn Medicine Center for Evidence-based Practice (CEP) Comparative effectiveness of troponin tests for diagnosis of myocardial infarction
2012 Blue Cross Blue Shield Association (BCBS) Special report: chronic noncancer pain—long-term opioid benefits and harms
2012 Blue Cross Blue Shield Association (BCBS) Bariatric surgery in patients with diabetes and body mass index less than 35 kg/m2
2012 Blue Cross Blue Shield Association (BCBS) Laparoscopic adjustable gastric banding in patients with body mass index less than 35 kg/m2 with weight-related comorbidity
2012 Blue Cross Blue Shield Association (BCBS) Wireless motility capsule in the diagnosis and evaluation of gastroparesis or slow-transit constipation
2012 Blue Cross Blue Shield Association (BCBS) Beta amyloid imaging with Positron Emission Tomography (PET) for evaluation of suspected alzheimer's disease or other causes of cognitive decline
2012 Blue Cross Blue Shield Association (BCBS) Accelerated radiotherapy after breast-conserving surgery for early stage breast cancer
2012 Blue Cross Blue Shield Association (BCBS) Special report: treatments for castration-resistant metastatic prostate cancer
2012 Blue Cross Blue Shield Association (BCBS) Multianalyte testing for the evaluation of adnexal masses
2012 Blue Cross Blue Shield Association (BCBS) Balloon sinus ostial dilation for treatment of chronic rhinosinusitis
2012 Blue Cross Blue Shield Association (BCBS) Sequencing-based tests to determine fetal down syndrome (trisomy 21) from maternal plasma DNA
2012 Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of human papillomavirus (HPV) testing, followed by liquid-based cytology triage of positive results, in primary screening for cervical cancer?
2012 Scottish Health Technologies Group (SHTG) High-risk human papillomavirus (HPV) testing as triage for women with mild or borderline cytology abnormalities
2012 Scottish Health Technologies Group (SHTG) Is radiofrequency ablation (RFA) treatment a suitable clinically and cost-effective treatment to be offered to patients with hepatocellular cancer in NHSScotland?
2012 Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of microprocessor-controlled artificial knees compared with non-microprocessor-controlled alternatives?
2012 Scottish Health Technologies Group (SHTG) Radiofrequency ablation for Barrett's oesophagus with high grade dysplasia
2012 Scottish Health Technologies Group (SHTG) The use of functional electrical stimulation (FES) in adults with dropped foot. This evidence note updates evidence note 25 published in October 2008
2012 Scottish Health Technologies Group (SHTG) Safety and risk associated with free standing midwife led maternity units. This evidence note updates evidence note 18 published in August 2007
2012 Scottish Health Technologies Group (SHTG) What implications does the organisation of vascular services have for rates of amputation?
2012 Scottish Health Technologies Group (SHTG) What is the published evidence of an association between hospital volume and outcome in elective carotid endarterectomy surgery?
2012 Scottish Health Technologies Group (SHTG) Is there a difference in operative mortality between endovascular aneurysm repair and open surgery in elective abdominal aortic aneurysm?
2012 Scottish Health Technologies Group (SHTG) What is the published evidence of an association between hospital volume and operative mortality for surgical repair (open and endovascular) of unruptured and ruptured abdominal aortic aneurysms?
2012 Scottish Health Technologies Group (SHTG) In patients with severe medically refractory gastroparesis (such as those requiring nutritional support), how effective and cost effective is gastric electrical stimulation (EnterraTM device) in reducing symptoms, reducing requirement for nutritional support or hospitalisation and improving quality of life, when compared with medical or alternative surgical management?
2012 Scottish Health Technologies Group (SHTG) What is the relative clinical effectiveness, cost effectiveness and safety of different bariatric surgery techniques (gastric bypass, gastric banding and sleeve gastrectomy)?
2012 Scottish Health Technologies Group (SHTG) In radiotherapy for cancer, what are the patient safety benefits and resource implications of the various in vivo methods of dosimetry to check received radiation dose, compared with pretreatment verification only?
2012 Scottish Health Technologies Group (SHTG) Is it clinically and cost effective to perform second-eye cataract surgery in the absence of other ocular co-morbidities in patients who have already had first-eye surgery?
2012 Scottish Health Technologies Group (SHTG) What is the impact of using thresholds (both for referral and surgery) for first-eye cataract surgery on the delivery of the cataract service and the resources associated with it?
2012 Scottish Health Technologies Group (SHTG) The clinical and cost-effectiveness of radiofrequency ablation for lung cancer
2012 Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of temporal artery thermometers compared with infrared in-ear thermometers for temperature measurement in routine clinical practice?
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Management and improvement in cancer pain: focusing on narcotic analgesics]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Comparative effectiveness study of catheter ablation for atrial fibrillation]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Clinically relevant venous thromboembolism following hip and knee arthroplasty]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Costing methods in healthcare]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Research on medical care utilization of stroke patients and related factors in Korea]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [A study on Korean adolescents' risk factors of suicide]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Risk factors at the regional level for suicide in the Korean elderly]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) Asian study on the value for a QALY: Korean results
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Diagnostic accuracy of anti-CCP antibody test in rheumatoid arthritis: systematic review]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Polysomnography in the diagnosis of sleep-related breathing disorders]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Efficacy of atomoxetine and methylphenidate in attention deficits hyperactivity disorder in adults: a rapid review]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [A systematic review of the diagnostic accuracy of FDG PET/PET-CT for fever of unknown origin]
2012 Andalusian Health Technology Assessment Area (AETSA) [Efficacy and safety of the immunoregulatory drugs interferon beta and glatiramer in the treatment of relapsing remitting multiple sclerosis]
2012 Agenzia nazionale per i servizi sanitari regionali (Agenas) FDG-PET/CT for cancer staging
2012 Agenzia nazionale per i servizi sanitari regionali (Agenas) New devices for the management of glycaemia in young diabetics
2012 Agenzia nazionale per i servizi sanitari regionali (Agenas) Polylactic-glycolic acid absorbable synthetic suture (Pgla) plus antibacterial: a systematic review
2012 Agenzia nazionale per i servizi sanitari regionali (Agenas) Renal artery ablation in patients with treatment-resistant hypertension: a systematic review
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Aspirin prescription pattern among diabetic patients for prevention of cardiovascular disease]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [The clinical effectiveness and economic analysis of bariatric surgery for severe obesity]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Economic evaluation of single tooth replacement: dental implant vs. bridge]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [A study of high-risk dyslipidemia for cardiocerebrovascular disease in Koreans]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Assessment of the effectiveness of sublingual immunotherapy and subcutaneous immunotherapy in allergic rhinitis and asthma]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [The clinical usefulness and cost-effectiveness of CT coronary angiography for the diagnosis of ischemic heart disease in patients with chest pain]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Small study effect and publication bias in systematic reviews with meta-analyses]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Utilization patterns and comparative effectiveness of inhaled bronchodilators/corticosteroids for patients with chronic airway diseases]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [A research on evidence-based healthcare for thyroid cancer screening: Part 2: Effectiveness of ultrasonographic screening for thyroid cancer]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Evaluating the health service and inequality in the health insurance coverage expansion for cancer; Before and after study: Part 1: Evaluation of the change in medical services before and after the enhancement of health insurance coverage of cancer]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [Evaluating the health service and inequality in the health insurance coverage expansion for cancer; Before and after study: Part 2: Evaluation of the impact in inequality before and after the enhancement of health insurance coverage of cancer]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [A study on current research status of psychiatric disorders, depression and suicide in Korea: Part Ⅰ. A study on current status and unmet need for the treatment of psychiatric disorders in Korea]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [A study on current research status of psychiatric disorders, depression and suicide in Korea: Part Ⅱ. Study on adolescent depression and suicide]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [A study on current research status of psychiatric disorders, depression and suicide in Korea: Part Ⅲ. A study on the current status and treatment promotion of comorbid depression among patients with cancer or patients with diabetes mellitus]
2012 National Evidence-based Healthcare Collaborating Agency (NECA) [A research on evidence-based healthcare for thyroid cancer screening: Part 1: the current status of thyroid cancer screening]
2012 Health Information and Quality Authority (HIQA) Economic evaluation of repeat universal antenatal screening for HIV in the third trimester of pregnancy
2012 Agency for Healthcare Research and Quality (AHRQ) Primary care relevant interventions for tobacco use prevention and cessation in children and adolescents: a systematic evidence review for the U.S. Preventive Services Task Force
2012 Agency for Healthcare Research and Quality (AHRQ) Screening for HIV in pregnant women: systematic review to update the U.S. Preventive Services Task Force Recommendation.
2012 Agency for Healthcare Research and Quality (AHRQ) Screening for HIV: systematic review to update the U.S. Preventive Services Task Force Recommendation
2012 Agency for Healthcare Research and Quality (AHRQ) Challenges in synthesizing and interpreting the evidence from a systematic review of multifactorial interventions to prevent functional decline in older adults
2012 Agency for Healthcare Research and Quality (AHRQ) Menopausal hormone therapy for the primary prevention of chronic conditions: systematic review to update the 2002 and 2005 U.S. Preventive Services Task Force Recommendations.
2012 Agency for Healthcare Research and Quality (AHRQ) Screening women for intimate partner violence and elderly and vulnerable adults for abuse: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation.
2012 Agency for Healthcare Research and Quality (AHRQ) Treatment for restless legs syndrome
2012 Agency for Healthcare Research and Quality (AHRQ) Strategies to reduce cesarean birth in low-risk women
2012 Agency for Healthcare Research and Quality (AHRQ) Comparison of characteristics of nursing homes and other residential long-term care settings for people with dementia
2012 Agency for Healthcare Research and Quality (AHRQ) Procalcitonin-guided antibiotic therapy
2012 Agency for Healthcare Research and Quality (AHRQ) Physical therapy interventions for knee pain secondary to osteoarthritis
2012 Agency for Healthcare Research and Quality (AHRQ) Treatment for hepatitis C virus infection in adults
2012 Agency for Healthcare Research and Quality (AHRQ) Progestogens for prevention of preterm birth
2012 Agency for Healthcare Research and Quality (AHRQ) Screening for hepatitis C virus infection in adults
2012 Agency for Healthcare Research and Quality (AHRQ) Screening, behavioral counseling, and referral in primary care to reduce alcohol misuse
2012 Agency for Healthcare Research and Quality (AHRQ) First-generation versus second-generation antipsychotics in adults: comparative effectiveness.
2012 Agency for Healthcare Research and Quality (AHRQ) Drug therapy for rheumatoid arthritis in adults: an update.
2012 Agency for Healthcare Research and Quality (AHRQ) Drug therapy for psoriatic arthritis in adults: update of a 2007 report.
2012 Agency for Healthcare Research and Quality (AHRQ) Dietary supplements in adults taking cardiovascular drugs
2012 Agency for Healthcare Research and Quality (AHRQ) Chronic kidney disease stages 1–3: screening, monitoring, and treatment.
2012 NIHR Health Technology Assessment programme Ruxolitinib for the treatment of myelofibrosis
2012 NIHR Health Technology Assessment programme Eltrombopag for the treatment of chronic immune thrombocytopenic purpura (ITP): a single technology appraisal
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Chemoembolization and radioembolization for the treatment of liver metastases]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Global postural re-education in spine diseases]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Photodynamic therapy for non-melanocytic skin cancer treatment]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Intensity modulated radiotherapy (IMRT) for prostate cancer]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Insulin Detemir therapy in pediatric and pregnant population]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Rituximab for the treatment of patients with chronic lymphocytic leukemia]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Photodynamic therapy for colon cancer]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Prophylaxis for thromboembolic disease with low molecular weight heparins in adult patients in home care]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Hyperbaric oxygen therapy in lateral sinus thrombosis]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [High frequency chest compression for ambulatory pulmonary physical therapy in patients with cystic fibrosis]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Cryopreservation of parathyroid glands for deferred autologous transplant in the management of hyperparathyroidism with surgical indication]
2012 Institute for Clinical Effectiveness and Health Policy (IECS) [Transient elastography (FibroScan®) for liver fibrosis staging]